Fortrea Holdings Inc
NASDAQ:FTRE
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
16.82
40.28
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Fortrea Holdings Inc
Other Non-Cash Items
Fortrea Holdings Inc
Other Non-Cash Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Non-Cash Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
F
|
Fortrea Holdings Inc
NASDAQ:FTRE
|
Other Non-Cash Items
$69.1m
|
CAGR 3-Years
-47%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Other Non-Cash Items
$700m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Danaher Corp
NYSE:DHR
|
Other Non-Cash Items
$760m
|
CAGR 3-Years
23%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Other Non-Cash Items
$19.1m
|
CAGR 3-Years
4%
|
CAGR 5-Years
41%
|
CAGR 10-Years
26%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Other Non-Cash Items
$186m
|
CAGR 3-Years
64%
|
CAGR 5-Years
12%
|
CAGR 10-Years
1%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Other Non-Cash Items
$186m
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
Fortrea Holdings Inc
Glance View
Fortrea Holdings Inc. operates in the dynamic sphere of Contract Research Organizations (CRO), carving out a niche in the healthcare and biopharmaceutical industries by providing essential services to companies looking to bring new medicinal products and treatments to market. At its core, Fortrea specializes in conducting clinical trials, integrating advanced data analytics, and ensuring regulatory compliance, vital for pharmaceutical firms that often lack the infrastructure to manage these complex processes internally. By offering an array of services—from initial research design through to the final stages of clinical trials—Fortrea positions itself as a critical partner in the drug development lifecycle. This includes preclinical, clinical, and post-approval phases, ensuring that the medicines undergoing testing meet stringent safety and efficacy standards, which is a significant challenge in today's growing demand for faster time-to-market in healthcare innovation. What sets Fortrea apart from many in its industry is its strategic approach to integrating technology with clinical research, leveraging data-driven insights to streamline processes and improve the accuracy of research outcomes. The company generates revenue by entering into contracts with pharmaceutical and biotechnology companies, charging fees for specific research and trial services. Fortrea’s ability to provide tailored solutions that encompass the breadth of clinical services—from design and optimization of clinical studies to statistical analysis and project management—ensures consistent demand for its offerings. In a world where pharmaceutical innovation dictates market share and competitiveness, Fortrea's role in enabling breakthroughs in medical treatments positions it as a cornerstone of the healthcare research community, driving both its relevance and profitability.
See Also
What is Fortrea Holdings Inc's Other Non-Cash Items?
Other Non-Cash Items
69.1m
USD
Based on the financial report for Dec 31, 2023, Fortrea Holdings Inc's Other Non-Cash Items amounts to 69.1m USD.
What is Fortrea Holdings Inc's Other Non-Cash Items growth rate?
Other Non-Cash Items CAGR 3Y
-47%
Over the last year, the Other Non-Cash Items growth was 8%. The average annual Other Non-Cash Items growth rates for Fortrea Holdings Inc have been -47% over the past three years .
You don't have any saved screeners yet